体外短波联合复方玄驹胶囊治疗ⅢB型前列腺炎相关的性功能障碍

The application effect of in vitro short-wave combined with compound Xuanju capsule in the treatment of ⅢB prostatitis related sexual dysfunction

目的:探讨体外短波联合复方玄驹胶囊在治疗ⅢB型前列腺炎相关的性功能障碍中的应用效果。方法:收集咸阳市第一人民医院和西电集团医院泌尿外科门诊2012年7月至2016年12月收治的患者341例,所有病例ⅢB型前列腺炎相关的性功能障碍诊断明确。将病例随机分为3组,其中观察组80例,行α1受体阻滞剂、复方玄驹胶囊、体外短波治疗。对照(1)组119例,行α1受体阻滞剂、复方玄驹胶囊治疗;对照(2)组142例,行α1受体阻滞剂、体外短波治疗。治疗前后三组均采用国际前列腺炎症状评分指数表(NIH-CPSI)和前列腺炎相关的性功能指数(PSFI)评分、焦虑自评量表(SAS)评分进行比较。结果:治疗后三组患者的NIH-CPSI和PSFI均有不同程度的改善,但观察组与对照组的改善程度差异具有统计学意义(P <0. 05)。结论:体外短波联合复方玄驹胶囊治疗ⅢB型前列腺炎所致的性功能障碍可明显改善症状,值得临床进一步推广。

Objective： To explore the application effect of in vitro short-wave combined with compound Xuanju capsule in the treatment of ⅢB prostatitis related sexual dysfunction. Methods： 341 cases of ⅢB prostatitis related sexual dysfunction,from the No,1 People＇s Hospital of Xianyang and Xi＇an XD Group Hospital,2010 July～2012 December,were observed. The patients were randomly divided into 3 groups. The observation group con-sisted of 80 patients undergoing α1 receptor blockers,compound Xuanju capsules and in vitro short-wave therapy.In the first control group,119 patients were treated with α1-blockers and compound Xuanju capsules; 142 patients in the second control group were treated with α1-blockers and in vitro short-wave therapy. Before and after treatment,all three groups were compared using the International Prostate Symptom Score Index Table（ NIH-CPSI）,Prostatitis-Related Sexual Function Index（ PSFI） Score,and Self-Rating Anxiety Scale（ SAS） Score. Results：There is distinct difference in the indexes on the 3 groups before and after treatment. But indexes of the observation group improved significantly better than the 2 control groups＇（ P〈0. 05）. Conclusions： It is worthy of further clinic promotion,In vitro short-wave combined with compound Xuanju capsule in treatment of IIIB prostatitis related sexual dysfunction,for which can obviously improve the symptom.